Invesco NASDAQ Biotechnology ETF
IBBQ
12 hedge funds and large institutions have $8.92M invested in Invesco NASDAQ Biotechnology ETF in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
41% more capital inflows, than outflows
Capital inflows: $1.03M | Capital outflows: $727K
33% more funds holding
Funds holding: 9 → 12 (+3)
9.42% less ownership
Funds ownership: 54.33% → 44.91% (-9.4%)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$502K |
| 2 |
Lake Street Advisors Group
Portsmouth,
New Hampshire
|
+$254K |
| 3 |
Partners Capital Investment Group
Boston,
Massachusetts
|
+$254K |
| 4 |
Capital Investment Advisory Services
Raleigh,
North Carolina
|
+$12.9K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$587K |
| 2 |
Tower Research Capital (TRC)
New York
|
-$107K |
| 3 |
Banco BTG Pactual
Rio De Janeiro,
Brazil
|
-$14K |
| 4 |
Capital Analysts LLC
Fort Washington,
Pennsylvania
|
-$13.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3K |
IBBQ Hedge Fund Activity: Q3 2022 in Review
12 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q3 2022, worth a combined $8.92M — up 3.9% from $8.59M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IBBQ positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Raymond James Financial Services Advisors, opening a new position worth an estimated $502K. The largest seller was Mirae Asset Global Investments, cutting an estimated $587K.
- 12 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q3 2022, up from 9 in Q2 2022.
- Funds reported $8.92M of Invesco NASDAQ Biotechnology ETF stock for Q3 2022, up 3.9% quarter-over-quarter.
- 4 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q3 2022 and 1 closed out, a net change of +3 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q3 2022 was Raymond James Financial Services Advisors, an estimated $502K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q3 2022 was Mirae Asset Global Investments, an estimated $587K sold.
Based on aggregated 13F filings for Q3 2022.